261 related articles for article (PubMed ID: 29882483)
1. Cardiovascular Morbidity and Mortality After Treatment of Hyperthyroidism with Either Radioactive Iodine or Thyroidectomy.
Ryödi E; Metso S; Huhtala H; Välimäki M; Auvinen A; Jaatinen P
Thyroid; 2018 Sep; 28(9):1111-1120. PubMed ID: 29882483
[TBL] [Abstract][Full Text] [Related]
2. Cardiovascular morbidity and mortality in surgically treated hyperthyroidism - a nation-wide cohort study with a long-term follow-up.
Ryödi E; Salmi J; Jaatinen P; Huhtala H; Saaristo R; Välimäki M; Auvinen A; Metso S
Clin Endocrinol (Oxf); 2014 May; 80(5):743-50. PubMed ID: 24304446
[TBL] [Abstract][Full Text] [Related]
3. Increased long-term cardiovascular morbidity among patients treated with radioactive iodine for hyperthyroidism.
Metso S; Auvinen A; Salmi J; Huhtala H; Jaatinen P
Clin Endocrinol (Oxf); 2008 Mar; 68(3):450-7. PubMed ID: 17941909
[TBL] [Abstract][Full Text] [Related]
4. Cancer Incidence and Mortality in Patients Treated Either With RAI or Thyroidectomy for Hyperthyroidism.
Ryödi E; Metso S; Jaatinen P; Huhtala H; Saaristo R; Välimäki M; Auvinen A
J Clin Endocrinol Metab; 2015 Oct; 100(10):3710-7. PubMed ID: 26262435
[TBL] [Abstract][Full Text] [Related]
5. Increased cardiovascular and cancer mortality after radioiodine treatment for hyperthyroidism.
Metso S; Jaatinen P; Huhtala H; Auvinen A; Oksala H; Salmi J
J Clin Endocrinol Metab; 2007 Jun; 92(6):2190-6. PubMed ID: 17374710
[TBL] [Abstract][Full Text] [Related]
6. Association of Radioactive Iodine, Antithyroid Drug, and Surgical Treatments With Solid Cancer Mortality in Patients With Hyperthyroidism.
Kitahara CM; Preston DL; Sosa JA; Berrington de Gonzalez A
JAMA Netw Open; 2020 Jul; 3(7):e209660. PubMed ID: 32701159
[TBL] [Abstract][Full Text] [Related]
7. A comparison of cardiovascular disease, cancer, mortality, and Graves' ophthalmopathy following treatment for hyperthyroidism: A Bayesian network meta-analysis.
Liu X; Wong CKH; Wu T; Chan WWL; Woo YC; Lam CLK; Lang BHH
World J Surg; 2024 Feb; 48(2):393-407. PubMed ID: 38686801
[TBL] [Abstract][Full Text] [Related]
8. MACE and Hyperthyroidism Treated With Medication, Radioactive Iodine, or Thyroidectomy.
Peng CC; Lin YJ; Lee SY; Lin SM; Han C; Loh CH; Huang HK; Pearce EN
JAMA Netw Open; 2024 Mar; 7(3):e240904. PubMed ID: 38436957
[TBL] [Abstract][Full Text] [Related]
9. Outcomes of Graves' Disease Patients Following Antithyroid Drugs, Radioactive Iodine, or Thyroidectomy as the First-line Treatment.
Liu X; Wong CKH; Chan WWL; Tang EHM; Woo YC; Lam CLK; Lang BHH
Ann Surg; 2021 Jun; 273(6):1197-1206. PubMed ID: 33914484
[TBL] [Abstract][Full Text] [Related]
10. Increased cancer incidence after radioiodine treatment for hyperthyroidism.
Metso S; Auvinen A; Huhtala H; Salmi J; Oksala H; Jaatinen P
Cancer; 2007 May; 109(10):1972-9. PubMed ID: 17393376
[TBL] [Abstract][Full Text] [Related]
11. Failure of radioactive iodine in the treatment of hyperthyroidism.
Schneider DF; Sonderman PE; Jones MF; Ojomo KA; Chen H; Jaume JC; Elson DF; Perlman SB; Sippel RS
Ann Surg Oncol; 2014 Dec; 21(13):4174-80. PubMed ID: 25001092
[TBL] [Abstract][Full Text] [Related]
12. Associating radioiodine therapy in hyperthyroidism with cancer mortality: robust or random results of a statistical analysis?
Iakovou I; Giannoula E; Chatzipavlidou V; Sachpekidis C
Hell J Nucl Med; 2020; 23(1):94-95. PubMed ID: 32361719
[TBL] [Abstract][Full Text] [Related]
13. Increased Cardiovascular Mortality and Morbidity in Patients Treated for Toxic Nodular Goiter Compared to Graves' Disease and Nontoxic Goiter.
Giesecke P; Rosenqvist M; Frykman V; Friberg L; Wallin G; Höijer J; Lönn S; Törring O
Thyroid; 2017 Jul; 27(7):878-885. PubMed ID: 28471268
[TBL] [Abstract][Full Text] [Related]
14. Cohort study on radioactive iodine-induced hypothyroidism: implications for Graves' ophthalmopathy and optimal timing for thyroid hormone assessment.
Stan MN; Durski JM; Brito JP; Bhagra S; Thapa P; Bahn RS
Thyroid; 2013 May; 23(5):620-5. PubMed ID: 23205939
[TBL] [Abstract][Full Text] [Related]
15. All-cause and cardiovascular mortality risk after surgery versus radioiodine treatment for hyperthyroidism.
Giesecke P; Frykman V; Wallin G; Lönn S; Discacciati A; Törring O; Rosenqvist M
Br J Surg; 2018 Feb; 105(3):279-286. PubMed ID: 29116656
[TBL] [Abstract][Full Text] [Related]
16. Duration of Hyperthyroidism and Lack of Sufficient Treatment Are Associated with Increased Cardiovascular Risk.
Lillevang-Johansen M; Abrahamsen B; Jørgensen HL; Brix TH; Hegedüs L
Thyroid; 2019 Mar; 29(3):332-340. PubMed ID: 30648498
[TBL] [Abstract][Full Text] [Related]
17. A Prospective Comparative Study on Improvement of Hyperthyroid Cardiovascular Dysfunction in Patients Undergoing Total Thyroidectomy Versus Medical Management.
Muthukumar S; Ravikumar K; Dhalapathy S; Gomathy T; Umadevi S; Maruthupandian D
World J Surg; 2018 May; 42(5):1408-1414. PubMed ID: 29532140
[TBL] [Abstract][Full Text] [Related]
18. Comparative Effectiveness of Treatment Choices for Graves' Hyperthyroidism: A Historical Cohort Study.
Sundaresh V; Brito JP; Thapa P; Bahn RS; Stan MN
Thyroid; 2017 Apr; 27(4):497-505. PubMed ID: 28049375
[TBL] [Abstract][Full Text] [Related]
19. High prevalence of side effects after recombinant human thyrotropin-stimulated radioiodine treatment with 30 mCi in patients with multinodular goiter and subclinical/clinical hyperthyroidism.
Romão R; Rubio IG; Tomimori EK; Camargo RY; Knobel M; Medeiros-Neto G
Thyroid; 2009 Sep; 19(9):945-51. PubMed ID: 19678745
[TBL] [Abstract][Full Text] [Related]
20. Attaining biochemical euthyroidism early after total thyroidectomy in Graves' disease may lower long-term morbidity risk.
Liu X; Wong CKH; Chan WWL; Tang EHM; Woo YC; Liu SYW; Lam CLK; Lang BHH
BJS Open; 2022 Jul; 6(4):. PubMed ID: 35822337
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
